Allostery Investments LP Aerovate Therapeutics, Inc. Transaction History
Allostery Investments LP
- $69.3 Billion
- Q1 2025
A detailed history of Allostery Investments LP transactions in Aerovate Therapeutics, Inc. stock. As of the latest transaction made, Allostery Investments LP holds 1,421,568 shares of AVTE stock, worth $3.81 Million. This represents 5.15% of its overall portfolio holdings.
Number of Shares
1,421,568
Previous 850,684
67.11%
Holding current value
$3.81 Million
Previous $2.25 Billion
58.28%
% of portfolio
5.15%
Previous 2.35%
Shares
2 transactions
Others Institutions Holding AVTE
# of Institutions
85Shares Held
32.4MCall Options Held
30.3KPut Options Held
57.9K-
Ra Capital Management, L.P. Boston, MA9.19MShares$24.6 Million0.48% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA3.76MShares$10.1 Million0.69% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA2.24MShares$6.01 Million1.35% of portfolio
-
Atlas Venture Life Science Advisors, LLC1.8MShares$4.82 Million1.32% of portfolio
-
Adar1 Capital Management, LLC Austin, TX1.46MShares$3.92 Million0.68% of portfolio
About Aerovate Therapeutics, Inc.
- Ticker AVTE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,448,100
- Market Cap $65.5M
- Description
- Aerovate Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of drugs that enhance the lives of patients with rare cardiopulmonary diseases in the United States. The company focuses on advancing AV-101, a dry powder inhaled formulation of imatinib for the treatment of pulmonary arterial hypertension, which ...